Cover Image: January 2012 Scientific American Magazine See Inside

Certain Brain Cells Become Toxic in Lou Gehrig's Disease

Brain cells known for assisting neurons may be killing them in patients with ALS














Share on Tumblr



Image: Stephen Waxman and Hank Morgan/Photo Researchers, Inc

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive neuromuscular disease that affects about 130,000 people worldwide a year. The vast majority of patients are isolated cases with no known family history of the disease. They usually start developing symptoms of the loss of motor neurons in middle age and die within five years of diagnosis. Researchers know very little about what causes ALS. Now a recent study in Nature Biotechnology suggests that the neuron death associated with the disease may be caused by astrocytes, a type of brain cell that normally helps neurons.

Previous research had suggested that astrocytes could become toxic in the rare form of ALS known to have genetic roots, and the study authors wanted to see if a similar phenomenon might happen in the more common iso­­lated cases. The answer turned out to be yes: when they cultured astro­cytes from those ALS patients, the healthy motor neurons in the culture began to die off after a few days. Other types of neurons were unaffected by the astrocytes, suggesting that they specifically harm the neurons involved in controlling the body’s movements.

Lead author Brian Kaspar, a neuroscientist at Ohio State University, and his collaborators next will attempt to figure out what makes the astrocytes behave this way. If researchers can understand why motor neurons die in ALS, they may have a better chance of finding a cure.


Buy This Issue
If your institution has site license access, enter here.

3 Comments

Add Comment
View
  1. 1. ZimJay 10:18 AM 1/25/12

    "If researchers can understand why motor neurons die in ALS, they may have a better chance of finding a cure."

    "If" begs the question...Where are all the ALS patients in the US coming from? (after you take away the sub-clinical gluten neuro-degenerative pathology) there is a group of post tramatic spinal injury ALS patients that believe the drug neurontin is a link to their ALS dx.See Big Al here: http://tinyurl.com/6wlpvej

    Next time you meet someone who just had a minor car/ski/sport accident and was rx'd neurontin/gabapetin (most common treatment) watch for the involuntary tongue fasciculation to appear. FYI

    Reply | Report Abuse | Link to this
  2. 2. Stagnaro 10:46 AM 1/25/12

    In order to face therapeutically at the best ALS, as well as all other brain disorders, including AD, Parkinson and Cancer, physicians aroun the world must familiarise with new concepts like brain disorder Inherited Real Risk, and Brain Sernsor Bedside Evaluation: See www.sisbq.org, Journal of Quantum Biophysical Semeiotics.

    Reply | Report Abuse | Link to this
  3. 3. ironjustice 03:13 AM 3/24/12

    "Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients."
    "Detrimental role of inappropriately chelated iron in ALS pathophysiology"
    http://www.ncbi.nlm.nih.gov/pubmed/22424123

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

Follow Us:

See what we're tweeting about

Scientific American MIND

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

Certain Brain Cells Become Toxic in Lou Gehrig's Disease: Scientific American Mind

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X